✦ LIBER ✦

The resynchronization therapy in narrow QRS study (RethinQ study): Methods and protocol design

✍ Scribed by John F. Beshai; Richard Grimm

Book ID: 106385069
Publisher: Springer
Year: 2007
Tongue: English
Weight: 243 KB
Volume: 19
Category: Article
ISSN: 1383-875X
DOI: 10.1007/s10840-007-9156-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The resynchronization therapy in narrow

The resynchronization therapy in narrow QRS study (RethinQ Study): Methods and protocol design

✍ John F. Beshai; Richard Grimm 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 42 KB

Effect of Cardiac Resynchronization Ther

Effect of Cardiac Resynchronization Therapy in Patients with Moderate Left Ventricular Systolic Dysfunction and Wide QRS Complex: A Prospective Study

✍ JEFFREY W.H. FUNG; Q. ZHANG; GABRIEL W.K. YIP; JOSEPH Y.S. CHAN; HAMISH C.K. CHA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Atrioventricular Junction Ablation Follo

Atrioventricular Junction Ablation Followed by Resynchronization Therapy in Patients with Congestive Heart Failure and Atrial Fibrillation (AVERT-AF) Study Design

✍ MOHAMED H. HAMDAN; ROGER A. FREEDMAN; EDWARD M. GILBERT; JOHN P. DIMARCO; KENNET 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Rationale, design and methods for proces

Rationale, design and methods for process evaluation in the HEALTHY study

✍ Schneider, M; Hall, W J; Hernandez, A E; Hindes, K; Montez, G; Pham, T; Rosen, L 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Ventricular Reverse Remodeling and 6-Mon

Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE Study

✍ Gregory W. Woo; Susan Petersen-Stejskal; James W. Johnson; Jamie B. Conti; Juan 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 120 KB

Guidelines for the design and implementa

Guidelines for the design and implementation of clinical studies in somatic cell therapy and gene therapy

✍ A. Lindemann; F. M. Rosenthal; R. Mertelsmann; S. Hase; P. Markmeyer 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 443 KB

According to Sects. 2 and 3 of the German drug statute, (Arzneimittelgesetz, AMG) gene technology and gene therapy products as well as somatic cell therapy products are regarded as drugs and are therefore subject to Sects. 40 and 41, stipulating the requirements for clinical studies designed to test